CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on improving cancer immunotherapy by developing a biomarker assay that predicts patient responses to treatment. Utilizing advanced bio-imaging technology, it aims to enhance the effectiveness of immune checkpoint inhibitors, potentially doubling survival rates for common solid tumors like lung canc…
Immunotherapy is a beacon of hope in cancer's battle, but with a 10-20% response rate in solid tumors, its potential is untapped.
Predicting patient responses to treatment, which current methods are ill-equipped for, is an urgent unmet medical need.
Our project stands for industrializing our analytically validated multiplexed protein-function based biomarker assay (IOO), currently TRL6, which is based on our proprietary bio-imaging technology.
Whilst scientifically validated, we need further cli…
FASTBASE SOLUTIONS SOCIEDAD LIMITADA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
